PTC Therapeutics CLO Mark Boulding sells $12,337 in stock
Related news
- BofA drops out of talks to arrange Moonshot AI's Hong Kong listing: report
- Targa Resources declares $1.25 dividend
- Thor raises dividend by 4% to $0.54
- China's September CPI rises 0.9% Y/Y, PPI accelerates to 5.0% above expectations
- Microsoft’s Azure chief seeks at least 20% cost cuts - report
- Federal judge indefinitely blocks Trump’s ban on three media outlets
- China's September trade surplus widens to $133.53B; exports up 36.3%, imports up 31.0%
-
Star Equity Holdings CEO Jeffrey Eberwein sells $27,400 preferred stock